91)Matched Molecular Pair Analysis in Drug Discovery, Dossetter, A.G.; Griffen,E.J.; Leach,A.G.; Drug Disco. Today. http://dx.doi.org/10.1016/j.drudis.2013.03.003
92) Highly diastereoselective radical cyclisations of chiral sulfinimines. Rochette EM, Lewis W, Dossetter AG, Stockman RA. Chem Commun (Camb). 2013 Oct 21;49(82):9395-7. doi: 10.1039/c3cc45452e.
93) Predicting the activity and toxicity of new psychoactive substances: a pharmaceutical industry perspective. Leach AG. Drug Test Anal. 2013 Dec 19. doi: 10.1002/dta.1593.
94) Achieving improved permeability by hydrogen bond donor modulation in a series of MGAT2 inhibitors. Scott. J. S.; Berry, D. J.; Brown, H. S.; Buckett, L.; Clarke, D. S.; Goldberg, K.; Hudson, J. A.; Leach, A. G.; MacFaul, P. A.; Raubo, P.; Robb, G. R. Med. Chem. Comm. 2013, 4, 1305-1311.
95) 'Big data' in pharmaceutical science: challenges and opportunities Dossetter, Ecker, Laverty & Overington Future Medicinal Chemistry, May 2014, Vol. 6, No. 8 , Pages 857-864 (doi: 10.4155/fmc.14.45)
96) Optimization of Brain Penetrant 11β-Hydroxysteroid Dehydrogenase Type I Inhibitors and in Vivo Testing in Diet-Induced Obese Mice Goldberg, F.W.; Dossetter, A.G.; Scott, J.S. Robb, G.R; Boyd, S.; Groombridge, S.D.; Kemmitt, P.D.; Sjogren, T.; Morentin-Gutierrez, P.; deSchoolmeester, J.; Swales, J.G.; Turnbull, A.V.; Wild, M.J. J. Med. Chem. 2014,57 (3), pp 970-986. DOI: 10.1021/jm4016729
97) Identification, Optimization, and Pharmacology of Acylurea GHS-R1a Inverse Agonists McCoull, W.; Barton, P., Brown, A. J. H. ; Bowker, S.S.; Cameron, J.; Clarke, D.S.; Davies, R. D. M.; Dossetter, A.G.; Ertan, A.; Fenwick, M.; Green, C.; Holmes, J.L.; Martin, N.; Masters, D.; Moore, J.E.; Newcombe, N.J.; Newton, C.; Pointon, H.; Robb, G.R.; Sheldon, C.;
98) Cytochrome P450 substrate recognition and binding” in Drug Metabolism Prediction, Kirchmair, J., ed. Leach, A. G.*; Kidley, N. J. 2014, 103-132.
99) Predicting the activity and toxicity of new psychoactive substances: a pharmaceutical industry perspective. Leach, A. G.* Drug Test. Analysis 2014, 6, 739-745.
100) Circumventing seizure activity in a series of G Protein Coupled Receptor 119 (GPR119) agonists. Scott, J. S.; Bowker, S. S.; Brocklehurst, K. J.; Brown, H. S.; Clarke, D. S.; Easter, A.; Ertan, A.; Goldberg, K. Hudson, J. A.; Kavanagh, S.; Laber, D.; Leach, A. G.; MacFaul, P. A.; Martin, E. A.; McKerrecher, D.; Schofield,
